Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|February 13, 1992
Treatment of HIV infection--progress in perspectiveL Corey, T R Fleming
Lifetime Data Analysis|April 24, 1999
Assessing effects on long-term survival after early termination of randomized trialsY Shen, T R Fleming
Oncology (Williston Park, N.Y.)|March 1, 1990
Interim analyses in clinical trialsS S Emerson, T R Fleming
Biometrics|June 1, 1989
Weighted Kaplan-Meier statistics: a class of distance tests for censored survival dataM S Pepe, T R Fleming
Statistics in Biopharmaceutical Research|June 9, 2015
A simulation study evaluating bio-creep risk in serial non-inferiority clinical trials for preservation of effectK Odem-Davis, T R Fleming
Controlled Clinical Trials|June 1, 1993
Monitoring of clinical trials: issues and recommendationsT R Fleming, D L DeMets
Annals of Internal Medicine|October 1, 1996
Surrogate end points in clinical trials: are we being misled?T R Fleming, D L DeMets
Journal of the National Cancer Institute|February 1, 1989
Approaches to monitoring clinical trialsT R Fleming, L F Watelet
Biometrics|September 1, 1989
Symmetric group sequential test designsS S Emerson, T R Fleming
Seminars in Oncology|October 1, 1988
Guidelines for the reporting of clinical trialsS J Green, T R Fleming
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|February 13, 1992
Treatment of HIV infection--progress in perspectiveL Corey, T R Fleming
Lifetime Data Analysis|April 24, 1999
Assessing effects on long-term survival after early termination of randomized trialsY Shen, T R Fleming
Oncology (Williston Park, N.Y.)|March 1, 1990
Interim analyses in clinical trialsS S Emerson, T R Fleming
Biometrics|June 1, 1989
Weighted Kaplan-Meier statistics: a class of distance tests for censored survival dataM S Pepe, T R Fleming
Statistics in Biopharmaceutical Research|June 9, 2015
A simulation study evaluating bio-creep risk in serial non-inferiority clinical trials for preservation of effectK Odem-Davis, T R Fleming
Controlled Clinical Trials|June 1, 1993
Monitoring of clinical trials: issues and recommendationsT R Fleming, D L DeMets
Annals of Internal Medicine|October 1, 1996
Surrogate end points in clinical trials: are we being misled?T R Fleming, D L DeMets
Journal of the National Cancer Institute|February 1, 1989
Approaches to monitoring clinical trialsT R Fleming, L F Watelet
Biometrics|September 1, 1989
Symmetric group sequential test designsS S Emerson, T R Fleming
Seminars in Oncology|October 1, 1988
Guidelines for the reporting of clinical trialsS J Green, T R Fleming
Pageof 12